Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk

Title: Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk

Volume: 14 Issue: 4

Author(s): A. K. Burroughs, E. Xirouchakis, A. Sigalas, P. Manousou, V. Calvaruso, M. Pleguezuelo, A. Corbani, S. Maimone and D. Patch

Affiliation:

Keywords: Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, vascular risk

Abstract: Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.

Cite this article as:

Burroughs K. A., Xirouchakis E., Sigalas A., Manousou P., Calvaruso V., Pleguezuelo M., Corbani A., Maimone S. and Patch D., Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk, Current Pharmaceutical Design 2008; 14 (4) . https://dx.doi.org/10.2174/138161208783497705